IL91778A - A method for reducing the heterogeneity of monoclonal antibodies - Google Patents
A method for reducing the heterogeneity of monoclonal antibodiesInfo
- Publication number
- IL91778A IL91778A IL9177889A IL9177889A IL91778A IL 91778 A IL91778 A IL 91778A IL 9177889 A IL9177889 A IL 9177889A IL 9177889 A IL9177889 A IL 9177889A IL 91778 A IL91778 A IL 91778A
- Authority
- IL
- Israel
- Prior art keywords
- antibodies
- incubation
- heterogeneity
- culture
- hours
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25078888A | 1988-09-28 | 1988-09-28 | |
US25078688A | 1988-09-28 | 1988-09-28 | |
US25078788A | 1988-09-28 | 1988-09-28 | |
US07/364,056 US5126250A (en) | 1988-09-28 | 1989-06-09 | Method for the reduction of heterogeneity of monoclonal antibodies |
CA000613379A CA1332367C (en) | 1988-09-28 | 1989-09-26 | Method for the reduction of heterogeneity of monoclonal antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
IL91778A true IL91778A (en) | 1994-10-07 |
Family
ID=27508376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9177889A IL91778A (en) | 1988-09-28 | 1989-09-26 | A method for reducing the heterogeneity of monoclonal antibodies |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0361902B1 (da) |
JP (1) | JP2925181B2 (da) |
CN (1) | CN1041392A (da) |
AR (1) | AR242986A1 (da) |
AT (1) | ATE101876T1 (da) |
AU (1) | AU615576B2 (da) |
BG (1) | BG60017B2 (da) |
CA (1) | CA1332367C (da) |
DE (1) | DE68913251T2 (da) |
DK (1) | DK475389A (da) |
ES (1) | ES2049332T3 (da) |
IE (1) | IE63562B1 (da) |
IL (1) | IL91778A (da) |
MX (1) | MX170441B (da) |
NZ (1) | NZ230786A (da) |
PL (1) | PL162260B1 (da) |
RO (1) | RO105652B1 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11046784B2 (en) | 2006-03-31 | 2021-06-29 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
EP1878747A1 (en) | 2006-07-11 | 2008-01-16 | greenovation Biotech GmbH | Glyco-engineered antibodies |
EP2031064A1 (de) * | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Steigerung von Proteintitern |
ES2687808T3 (es) | 2007-09-26 | 2018-10-29 | Chugai Seiyaku Kabushiki Kaisha | Región constante de anticuerpo modificado |
SI2202245T1 (sl) | 2007-09-26 | 2016-10-28 | Chugai Seiyaku Kabushiki Kaisha | Postopek modificiranja izoelektrične točke protitelesa preko aminokislinske substitucije v CDR |
PL2275443T3 (pl) | 2008-04-11 | 2016-05-31 | Chugai Pharmaceutical Co Ltd | Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny |
TWI440469B (zh) * | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
JP5717624B2 (ja) | 2009-03-19 | 2015-05-13 | 中外製薬株式会社 | 抗体定常領域改変体 |
TWI544077B (zh) | 2009-03-19 | 2016-08-01 | Chugai Pharmaceutical Co Ltd | Antibody constant region change body |
MX365235B (es) | 2010-11-30 | 2019-05-28 | Chugai Pharmaceutical Co Ltd | Molécula de unión a antígeno capaz de unir repetidamente a la pluralidad de moléculas de antígeno. |
AU2011350456B2 (en) * | 2010-12-28 | 2016-05-26 | Chugai Seiyaku Kabushiki Kaisha | Animal cell culturing method |
PT3489254T (pt) | 2012-04-30 | 2022-12-30 | Biocon Ltd | Proteínas de fusão direcionadas/imunomoduladoras e seus métodos de fabrico |
RU2662991C2 (ru) * | 2013-03-12 | 2018-07-31 | Биокон Лтд. | Слитые иммуномодулирующие белки и способы их получения |
JP6442404B2 (ja) | 2013-06-11 | 2018-12-19 | 国立研究開発法人国立精神・神経医療研究センター | 再発寛解型多発性硬化症(rrms)患者の治療予後予測方法、及び新規治療適応判断方法 |
CA2972393A1 (en) | 2015-02-27 | 2016-09-01 | Chugai Seiyaku Kabushiki Kaisha | Composition for treating il-6-related diseases |
US10697883B2 (en) | 2015-05-19 | 2020-06-30 | National Center Of Neurology And Psychiatry | Method for determining application of therapy to multiple sclerosis (MS) patient |
HUE054420T2 (hu) * | 2016-10-17 | 2021-09-28 | Enzene Biosciences Ltd | Folyamatos eljárás terápiás fehérje heterogenitásának csökkentésére |
US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
JP7235249B2 (ja) | 2017-10-20 | 2023-03-08 | 学校法人兵庫医科大学 | 抗il-6受容体抗体を含有する術後の癒着を抑制するための医薬組成物 |
-
1989
- 1989-09-26 CA CA000613379A patent/CA1332367C/en not_active Expired - Fee Related
- 1989-09-26 AR AR89310004A patent/AR242986A1/es active
- 1989-09-26 RO RO141765A patent/RO105652B1/ro unknown
- 1989-09-26 IL IL9177889A patent/IL91778A/en not_active IP Right Cessation
- 1989-09-26 NZ NZ230786A patent/NZ230786A/xx unknown
- 1989-09-26 BG BG089846A patent/BG60017B2/bg unknown
- 1989-09-27 PL PL89281598A patent/PL162260B1/pl unknown
- 1989-09-27 AU AU42343/89A patent/AU615576B2/en not_active Ceased
- 1989-09-27 DE DE68913251T patent/DE68913251T2/de not_active Expired - Fee Related
- 1989-09-27 ES ES89309851T patent/ES2049332T3/es not_active Expired - Lifetime
- 1989-09-27 IE IE309489A patent/IE63562B1/en not_active IP Right Cessation
- 1989-09-27 DK DK475389A patent/DK475389A/da not_active Application Discontinuation
- 1989-09-27 MX MX017721A patent/MX170441B/es unknown
- 1989-09-27 AT AT89309851T patent/ATE101876T1/de not_active IP Right Cessation
- 1989-09-27 EP EP89309851A patent/EP0361902B1/en not_active Expired - Lifetime
- 1989-09-28 CN CN89107508.9A patent/CN1041392A/zh active Pending
- 1989-09-28 JP JP1256890A patent/JP2925181B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE68913251T2 (de) | 1994-06-23 |
AU4234389A (en) | 1990-04-05 |
JP2925181B2 (ja) | 1999-07-28 |
PL162260B1 (pl) | 1993-09-30 |
BG60017B2 (bg) | 1993-06-30 |
CN1041392A (zh) | 1990-04-18 |
ES2049332T3 (es) | 1994-04-16 |
AR242986A1 (es) | 1993-06-30 |
RO105652B1 (ro) | 1992-11-30 |
CA1332367C (en) | 1994-10-11 |
DK475389A (da) | 1990-03-29 |
NZ230786A (en) | 1991-11-26 |
AU615576B2 (en) | 1991-10-03 |
MX170441B (es) | 1993-08-23 |
DE68913251D1 (de) | 1994-03-31 |
EP0361902A3 (en) | 1990-08-16 |
EP0361902A2 (en) | 1990-04-04 |
EP0361902B1 (en) | 1994-02-23 |
JPH02163096A (ja) | 1990-06-22 |
DK475389D0 (da) | 1989-09-27 |
ATE101876T1 (de) | 1994-03-15 |
IE893094L (en) | 1990-03-28 |
IE63562B1 (en) | 1995-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5126250A (en) | Method for the reduction of heterogeneity of monoclonal antibodies | |
EP0361902B1 (en) | Method for the reduction of heterogeneity of monoclonal antibodies | |
RU2252961C2 (ru) | Способ получения амидированного пептида | |
US4954437A (en) | Cell encoding recombinant human erythropoietin | |
EP0732404A1 (en) | Novel expression screening vector | |
WO1986004336A1 (en) | Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses | |
EP0162034B1 (en) | Method of isolating monoclonal antibodies from hybridoma cultures | |
EP0169239A1 (en) | HUMAN ERYTHROPOIETIN cDNA CLONES | |
KR960013460B1 (ko) | 안티-pci 모노클로날 항체 | |
EP0300459A2 (en) | Human pancreatic secretory trypsin inhibitor | |
EP0816504A2 (en) | Platelet activating factor acetylhdrolase, and gene thereof | |
EP0519728A2 (en) | Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies | |
JPH10226700A (ja) | Miaの検出のためのイムノアッセイ | |
JPH09235300A (ja) | ヒトtimp−3及び抗ヒトtimp−3モノクローナル抗体並びにその用途 | |
Inagami | Purification of renin and prorenin. | |
Ishizuka et al. | Characterization of monoclonal antibodies against human prorenin profragment and identification of active prorenins in plasma | |
JP4361579B2 (ja) | コンドロイチナーゼabcに対するモノクローナル抗体 | |
JP4090486B2 (ja) | コンドロイチン硫酸リアーゼiiに対するモノクローナル抗体 | |
EP0559428B1 (en) | Novel polypeptides and DNAs encoding them | |
JPS61221128A (ja) | プラスミノ−ゲン活性化因子に対するモノクロ−ナル抗体とその調製方法及び該モノクロ−ナル抗体の使用方法 | |
JP4361578B2 (ja) | コンドロイチン硫酸リアーゼiiに対するモノクローナル抗体 | |
AU752369B2 (en) | TNF-alpha converting enzyme | |
JP4090487B2 (ja) | コンドロイチナーゼabcに対するモノクローナル抗体 | |
WO2000009739A1 (fr) | Anticorps monoclonal agissant contre la trypsine canine | |
KR19980701550A (ko) | 항-트롬보포이에틴 단일클론 항체(anti-tpo monoclonal antibodies) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |